Public Perception of Genetic Engineering: Insights Before and After the CRISPR Era

The introduction of CRISPR-Cas9 in 2012 was a groundbreaking moment in the field of genetics, offering a more accessible method for precise genome modifications. This advancement has not only transformed genetic research but also ignited debates on the ethical implications of modifying human and animal genomes. There’s been a surge in both scientific and public interest, leading to extensive studies aimed at gauging public opinion on genetic engineering.
A recent systematic review sheds light on the evolving public perceptions towards genetic modification both before and after CRISPR-Cas9’s debut. Conducted over a span of 35 years, the review chronicled public attitudes in various regions, including Asia, Europe, and North America, through an in-depth examination of questionnaire surveys. You can access the original study for more details here.
Before CRISPR, public discussions largely revolved around the potential medical applications of genetic engineering in humans, such as gene therapies aimed at curing genetic diseases. Conversely, the idea of genetic enhancement in humans was met with skepticism and often outright rejection. The public’s concern centered on ethical considerations, such as the naturalness of altering the human genome and potential societal impacts.
Post-CRISPR, while the overall acceptance of genome editing for treating diseases has increased, attitudes remain mixed regarding non-therapeutic enhancements. The differentiation between therapeutic and non-therapeutic uses remains significant; there’s strong support for treating severe genetic conditions but hesitance and ethical reservations persist regarding enhancements, such as altering intelligence or physical attributes.
The stance on genetically modifying animals similarly hinges on intended use—medical applications, such as producing organs for transplantation, receive higher acceptance compared to the use of genetic changes for food production.
The relationship between public awareness and attitude is complex. Generally, better-informed individuals tend to show greater support for genetic technologies, although this correlation is sometimes weak.
This comprehensive review also highlights methodological aspects of the surveys included, underscoring the need for standardized approaches to ensure consistency across future studies.
As genetic engineering technologies like CRISPR continue to advance, public consultation will be crucial, especially as these applications may directly impact everyday lives. This review underscores the importance of inclusive dialogue and informed policy-making to align technological innovation with societal values and expectations.
For more detailed insights, the original study and its supplementary materials offer further context and understanding of this evolving landscape.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

U.S. Precision Medicine Market Set to Triple by 2033

The U.S. precision medicine market is projected to expand from USD 24.95 billion in 2023 to a staggering USD 76.12 billion by 2033, driven by a compound annual growth rate (CAGR) of 11.80% from 2024 to 2033.

By |January 1, 2025|Categories: Article, Healthcare, Market Trends|Tags: , |0 Comments

The Future of Cybersecurity: Resilience’s Predictions for 2025

"As we edge closer to 2025, experts from the cybersecurity firm Resilience have shared their insights, shedding light on the challenges and transformations that lie ahead."

By |January 1, 2025|Categories: Article, Cybersecurity, Insurance Industry|Tags: |0 Comments

Revolutionizing Healthcare: NHS Trials AI Tool for Early Diabetes Detection

In an unprecedented leap for preventive medicine, the National Health Service (NHS) in England is poised to trial Aire-DM, a groundbreaking AI tool designed to predict the risk of type 2 diabetes a remarkable 13 years before its onset.

Revolutionizing Skin Cancer Diagnosis with AI: Efficacy and Future Prospects

In a groundbreaking study, AI shows potential to match or surpass specialists in diagnosing skin cancer, challenging traditional dermatological practices.

By |December 31, 2024|Categories: Article, Artificial Intelligence, Healthcare|Tags: |0 Comments

The Dawn of Personalized Medicine: AI’s Transformative Role in Healthcare

In a world where the promise of personalized medicine is finally being realized, Erez Meltzer, CEO & Board Member of Nanox, stands at the forefront of this revolution.

DeFi: Revolutionizing the Financial Landscape

In a compelling exploration of the financial landscape, Himanshu Kumar, CEO of AMBCrypto, delves into the transformative potential of Decentralized Finance (DeFi) and its implications for traditional banking. Highlighting DeFi's revolutionary approach, Kumar discusses how the democratization of financial services through blockchain technology is reshaping access, breaking down barriers, and challenging established institutions.

By |December 31, 2024|Categories: Article, Finance, Technology|Tags: , |0 Comments